Biogen: FDA to rule on Tysabri
MarketWatch - USA
... that they expect the US Food and Drug Administration to make a decision by the end of March to clear the market return of the company's recalled drug, Tysabri. ...
See all stories on this topic

Elan Tysabri Could Hit $1.8B Sales - NCB
New Ratings - USA
1305 GMT [Dow Jones] NCB Stockbrokers says $1.6B in peak sales for suspended MS drug Tysabri are factored into the share price of over $14. ...

Boston booked record 108 conventions last year
Boston Globe - United States
... said its Tysabri multiple sclerosis medicine, suspended in 2005 after being linked to an often fatal nervous system disease, may return to the market this year ...

UK Stocks Climb, Paced by RBS, HBOS, P&O, British Airways
Bloomberg - USA
... in Dublin. US partner Biogen Idec Inc. said the Tysabri multiple-sclerosis medicine may return to the market this year. The drug ...

11am Markets Update
RTE.ie - Ireland
... Dublin's ISEQ had gained 50 points to stand at 7,473 with shares in Elan up 34 cent to €12.20 after a positive outlook for the MS drug Tysabri from its ...